Phase 1b of WNT inhibitor ipafricept (IPA, decoy receptor for WNT ligands) with carboplatin (C) and paclitaxel (P) in recurrent platinum-sensitive ovarian cancer (OC).-Reference-Cited by-同舟云学术

Phase 1b of WNT inhibitor ipafricept (IPA, decoy receptor for WNT ligands) with carboplatin (C) and paclitaxel (P) in recurrent platinum-sensitive ovarian cancer (OC).

Published:2016-05-20 Issue:15_suppl Volume:34 Page:2515-2515
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

O'Cearbhaill Roisin Eilish¹,McMeekin D. Scott²,Mantia-Smaldone Gina³,Gunderson Camille²,Sabbatini Paul¹,Cattaruzza Fiore⁴,Fischer Marcus⁴,Kapoun Ann M.⁴,Xu Lu⁴,Dupont Jakob⁴,Brachmann Rainer Karl⁴,Farooki Azeez¹,Moore Kathleen N.²

Affiliation:

1. Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY;

2. University of Oklahoma Health Sciences Center, Oklahoma City, OK;

3. Fox Chase Cancer Center, Philadelphia, PA;

4. OncoMed Pharmaceuticals Inc., Redwood City, CA;

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2016.34.15_suppl.2515

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-dialyzable uremic toxins and renal tubular cell damage in CKD patients: a systems biology approach;European Journal of Medical Research;2024-08-09

2. Chemotherapy resistance in epithelial ovarian cancer: Mechanisms and emerging treatments;Seminars in Cancer Biology;2021-12

3. Ovarian Cancer and Cancer Stem Cells—Cellular and Molecular Characteristics, Signaling Pathways, and Usefulness as a Diagnostic Tool in Medicine and Oncology;Cancers;2021-08-19

4. Impact of Wnt/β-Catenin Inhibition on Cell Proliferation through CDC25A Downregulation in Soft Tissue Sarcomas;Cancers;2020-09-08

5. Novel Therapeutic Strategies for Ovarian Cancer Stem Cells;Frontiers in Oncology;2020-03-17